Novavax begins Phase III Covid-19 vaccine trial in the US and Mexico
Biotech firm Novavax has initiated a pivotal Phase III study of its Covid-19 vaccine candidate,...
Biotech firm Novavax has initiated a pivotal Phase III study of its Covid-19 vaccine candidate,...
Clinical stage biotechnology company Acticor Biotech has recruited the first patient in Phase II GARDEN...
Chinese company Sinovac Biotech’s Covid-19 vaccine, CoronaVac, has reportedly passed the 50% threshold for efficacy...
Brazil National Health Surveillance Agency Anvisa has suspended a clinical trial of Chinese biopharma firm...
Brazilian health agency Anvisa has announced that a volunteer in the Brazilian trial of AstraZeneca...
RedHill Biopharma has submitted an application to Mexico's COFEPRIS and initiated a filing with Brazil's...
India-based Zydus Cadila has secured approval from the Mexican regulatory agency COFEPRIS for clinical studies...
The Brazilian National Regulatory Agency, Anvisa, has given approval to a Phase III clinical trial...
India-based pharmaceutical company Zydus has received approval from the Mexican regulatory authority, COFEPRIS, to assess...
Researchers in South Africa and Brazil have initiated clinical trials to assess a Covid-19 vaccine...